Low Dose Naltrexone Conference - Sat... 
GloriousHope
16 y
5,911
† Cross †
Hello all,
For those interested in Low Dose Naltrexone (LDN), the annual LDN conference is being held on Saturday, 10/11/08 in Los Angeles, California. They are having a number of doctors (including Dr. Burt Berkson) from around the world who use LDN in treating a wide variety of illnesses - from AutoImmune Diseases (Multiple Sclerosis, Crohn’s, Rheumatoid Arthritis, Lupus, Hepatitis, etc.), to Cancer, to viral diseases (HIV/AIDS), to Autism (see the below excerpt from the LDN Website). It is a free conference, but attendees are asked to please contribute towards the HIV/AIDS / LDN Clinical Trial that is being conducted by Dr. McCandless in Africa. Per a recent message from the Conference Organizer on Thursday, 10/9, she stated "ANYONE can come to the conference and register on site. We have over 100 seats left in the Mayer Auditorium. What I cannot promise is food service for the walk-ins, as I have to give the final count to USC catering when I arrive on campus this afternoon. Details: http://www.ldninfo.org/conf2008.htm"
If anyone is in the Los Angeles area and able to attend, it will be worth the trip!
Also, as has been done in the past, the conference will be videotaped for those who are not able to attend. The LDN Website (http://www.ldninfo.org/) normally has the multi-media posted a few months after the conference. The LDN Website also contains multi-media for the past 3 conferences, as well as a NIH/National Cancer Institute Conference.
Cheers ~~ Joyce
Excerpt from http://www.ldninfo.org/conf2008.htm“About the Conference
The Fourth Annual Low Dose Naltrexone (LDN) Conference will be held on Saturday, October 11th, 2008 in the Mayer Auditorium of the Keith Administration Building at the Health Sciences Campus of the University of Southern California (USC) in Los Angeles, California.
The conference theme, "A Revolution In Research", was selected because it reflects the increasing appearance of LDN articles in medical journals and the growth of LDN use in clinical practice.
During the course of the day, the attendees, who come from the far corners of the world as well as from Europe, can expect to be treated to a series of expert presentations from a number of researchers, physicians, and LDN advocates.
Presenters scheduled to speak include:- Dr. David Gluck — Emcee and overview of "The Year in LDN."
- Dr. Jaquelyn McCandless — The study of LDN for HIV in Mali as well as information on LDN for Autism. (Note: Dr. McCandless will also be discussing her experiencing using LDN with Crohn's , Fibromyalgia, Cancer, Chronic Fatigue Syndrome, Sjogren's, Parkinsons, Multiple Sclerosis)
- Aristo Vojdani, PhD, will be joining the scheduled presentation by
Dr. Jaquelyn McCandless at the Fourth LDN Conference on October 11th in L.A. His subject will be "Mechanisms Associated with Low Dose
Naltrexone Therapy in Autism and HIV". - Dr. Burt Berkson — Private practice experiences with LDN for cancer and autoimmune diseases. (Note: Dr. Berkson is one of the pioneers in Alpha Lipoic Acid and in treating Hepatitis with Integrative Medicine.)
- Dr. Tom Gilhooly — Clinical trial in Scotland on urological effects of LDN in multiple sclerosis.
- Dr. Maira Gironi — A multi-institutional clinical trial of LDN for MS in Italy.
- Dr. Skip Lenz — Pharmacy survey of patients using LDN. “
More
- Dr. David Gluck — Emcee and overview of "The Year in LDN."
Share:
Translate This Page: